Our findings that PDGFB-driven tumors in qMCP-deficient mice have increased expression of MES genes, increased expression of MES marker CD44, and increased hypoxia upon IHC staining are consistent with a transition from a PN- > MES GBM subtype (Fig. 4)14. This evidence concerns the gene CD44 and glioblastoma.